T-cell-based therapies for malignancy and infection in childhood

Nabil Ahmed, Helen E. Heslop, Crystal L. Mackall

Research output: Contribution to journalArticle

Abstract

One major advance in T-cell-based immunotherapy in the last 20 years has been the molecular definition of numerous viral and tumor antigens. Adoptive T-cell transfer has shown definite clinical benefit in the prophylaxis and treatment of viral infections that develop in pediatric patients after allogeneic transplant and in posttransplant lymphoproliferative disease associated with the Epstein-Barr virus. Developing adoptive T-cell therapies for other malignancies presents additional challenges. This article describes the recent advances in T-cell-based therapies for malignancy and infection in childhood and strategies to enhance the effector functions of T cells and optimize the cellular product, including gene modification and modulation of the host environment.

Original languageEnglish (US)
Pages (from-to)83-96
Number of pages14
JournalPediatric Clinics of North America
Volume57
Issue number1
DOIs
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Cell- and Tissue-Based Therapy
T-Lymphocytes
Infection
Neoplasms
Adoptive Transfer
Viral Tumor Antigens
Virus Diseases
Human Herpesvirus 4
Immunotherapy
Pediatrics
Transplants
Genes
Therapeutics

Keywords

  • Adoptive immunotherapy
  • Chimeric antigen receptor
  • Hematopoietic stem cell transplantation
  • Immune reconstitution
  • Lymphopenia
  • Pediatrics
  • Tumor antigens
  • Tumor vaccines

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

T-cell-based therapies for malignancy and infection in childhood. / Ahmed, Nabil; Heslop, Helen E.; Mackall, Crystal L.

In: Pediatric Clinics of North America, Vol. 57, No. 1, 02.2010, p. 83-96.

Research output: Contribution to journalArticle

Ahmed, Nabil ; Heslop, Helen E. ; Mackall, Crystal L. / T-cell-based therapies for malignancy and infection in childhood. In: Pediatric Clinics of North America. 2010 ; Vol. 57, No. 1. pp. 83-96.
@article{97bbb21642f74c1d88b896ebff9a1451,
title = "T-cell-based therapies for malignancy and infection in childhood",
abstract = "One major advance in T-cell-based immunotherapy in the last 20 years has been the molecular definition of numerous viral and tumor antigens. Adoptive T-cell transfer has shown definite clinical benefit in the prophylaxis and treatment of viral infections that develop in pediatric patients after allogeneic transplant and in posttransplant lymphoproliferative disease associated with the Epstein-Barr virus. Developing adoptive T-cell therapies for other malignancies presents additional challenges. This article describes the recent advances in T-cell-based therapies for malignancy and infection in childhood and strategies to enhance the effector functions of T cells and optimize the cellular product, including gene modification and modulation of the host environment.",
keywords = "Adoptive immunotherapy, Chimeric antigen receptor, Hematopoietic stem cell transplantation, Immune reconstitution, Lymphopenia, Pediatrics, Tumor antigens, Tumor vaccines",
author = "Nabil Ahmed and Heslop, {Helen E.} and Mackall, {Crystal L.}",
year = "2010",
month = "2",
doi = "10.1016/j.pcl.2009.11.002",
language = "English (US)",
volume = "57",
pages = "83--96",
journal = "Pediatric Clinics of North America",
issn = "0031-3955",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - T-cell-based therapies for malignancy and infection in childhood

AU - Ahmed, Nabil

AU - Heslop, Helen E.

AU - Mackall, Crystal L.

PY - 2010/2

Y1 - 2010/2

N2 - One major advance in T-cell-based immunotherapy in the last 20 years has been the molecular definition of numerous viral and tumor antigens. Adoptive T-cell transfer has shown definite clinical benefit in the prophylaxis and treatment of viral infections that develop in pediatric patients after allogeneic transplant and in posttransplant lymphoproliferative disease associated with the Epstein-Barr virus. Developing adoptive T-cell therapies for other malignancies presents additional challenges. This article describes the recent advances in T-cell-based therapies for malignancy and infection in childhood and strategies to enhance the effector functions of T cells and optimize the cellular product, including gene modification and modulation of the host environment.

AB - One major advance in T-cell-based immunotherapy in the last 20 years has been the molecular definition of numerous viral and tumor antigens. Adoptive T-cell transfer has shown definite clinical benefit in the prophylaxis and treatment of viral infections that develop in pediatric patients after allogeneic transplant and in posttransplant lymphoproliferative disease associated with the Epstein-Barr virus. Developing adoptive T-cell therapies for other malignancies presents additional challenges. This article describes the recent advances in T-cell-based therapies for malignancy and infection in childhood and strategies to enhance the effector functions of T cells and optimize the cellular product, including gene modification and modulation of the host environment.

KW - Adoptive immunotherapy

KW - Chimeric antigen receptor

KW - Hematopoietic stem cell transplantation

KW - Immune reconstitution

KW - Lymphopenia

KW - Pediatrics

KW - Tumor antigens

KW - Tumor vaccines

UR - http://www.scopus.com/inward/record.url?scp=77951071901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951071901&partnerID=8YFLogxK

U2 - 10.1016/j.pcl.2009.11.002

DO - 10.1016/j.pcl.2009.11.002

M3 - Article

C2 - 20307713

AN - SCOPUS:77951071901

VL - 57

SP - 83

EP - 96

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

SN - 0031-3955

IS - 1

ER -